Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Program
        • PEP++ project
        • PEP4LEP 2.0 & PEP4LEP
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • Prevention of Leprosy (SDR-PEP) Toolkit
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Soluble mediators of immune significance in sera of leprosy patients

Dubey A, Gaur R, Arela N, et al. Lepra. Leprosy Review. 2020; 91 (4) : 403-412.
Download PDF
Publication

Depression and anxiety in people affected by leprosy and lymphatic filariasis: a cross-sectional study in four States in India

Mangeard-Lourme J, Robert de Arquer G, Parasa J, et al. Lepra. Leprosy Review. 2020; 91 (4) : 367-382.
Download PDF
Publication

“Leprosy Is Curable” – A New Teaching Aid for ASHA Health Workers (Hindi)

Sasakawa Health Foundation . 2020;
Download PDF
Publication

Leprosy perceptions and knowledge in endemic districts in India and Indonesia: Differences and commonalities.

van 't Noordende A, Lisam S, Ruthindartri P, et al. PLoS neglected tropical diseases. 2021; 15 (1) : e0009031.
Download PDF
Publication

Burden of depression and anxiety among leprosy affected and associated factors-A cross sectional study from India.

Govindasamy K, Jacob I, Solomon R, et al. PLoS neglected tropical diseases. 2021; 15 (1) : e0009030.
Download PDF
Publication

Computer assisted customized footwear and traditional micro-cellular rubber (MCR) footwear to reduce recurrence of ulcer for patients with loss of sensation due to leprosy

Govindasamy K, Raja NR, Gupta P, et al. Leprosy Review. 2020; 91 (4) : 383-392.
Download PDF
Publication

Ultrasound guided Fine needle aspiration cytology in diagnosing Primary neuritic leprosy cases at Sub-Himalayan region of West Bengal

Haldar N, Haldar , Saha , et al. IOSR Journal of Dental and Medical Sciences. 2020; 19 (12) : 23-27.
Download PDF
Publication

A single dose of rifampicin to prevent leprosy; quantitative analysis of impact on perception, attitudes and behaviour of persons affected, contacts and community members towards leprosy in India, Nepal and Indonesia

Mieras L, Singh MK, Manglani P R, et al. Leprosy Review. 2020; 91 (4) : 314-327.
Download PDF
Publication

Cytomorphological patterns of Nerve aspirates in Pure Neuritic Leprosy—A single centre cross-sectional observational study

Sandhu S, Raman D, Sood A, et al. Medknow. Journal of Cytology. 2021;
Download PDF
Publication

Leprosy - the current target in national programmes.

Thangaraju P, Venkatesan N, Siddarth S, et al. Journal of family medicine and primary care. 2020; 9 (10) : 5409-5410.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 66
  • Next page ››
Subscribe to India

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD